| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
100,950 |
96,452 |
$6.31M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
74,684 |
68,533 |
$3.33M |
| H2022 |
Community-based wrap-around services, per diem |
2,529 |
1,511 |
$3.25M |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
2,296 |
2,144 |
$1.35M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,381 |
14,010 |
$1.15M |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
3,766 |
3,586 |
$1.04M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,661 |
17,834 |
$1.03M |
| 99215 |
Prolong outpt/office vis |
8,984 |
8,486 |
$880K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
19,301 |
18,168 |
$788K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,634 |
8,248 |
$684K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,678 |
5,469 |
$663K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
11,666 |
11,249 |
$632K |
| 99460 |
|
7,189 |
7,076 |
$596K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
9,499 |
9,016 |
$593K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
9,476 |
9,242 |
$584K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,444 |
6,019 |
$572K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
5,378 |
5,079 |
$553K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,614 |
6,399 |
$500K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
9,798 |
4,135 |
$443K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
10,586 |
8,356 |
$371K |
| 71045 |
Radiologic examination, chest; single view |
60,853 |
45,500 |
$369K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,017 |
3,958 |
$350K |
| 70450 |
Computed tomography, head or brain; without contrast material |
13,258 |
12,296 |
$348K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,721 |
2,617 |
$346K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,101 |
3,943 |
$342K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,742 |
3,686 |
$342K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,280 |
3,178 |
$323K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,858 |
3,453 |
$297K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
6,762 |
6,562 |
$296K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,066 |
4,947 |
$293K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
6,499 |
5,960 |
$292K |
| 88307 |
|
3,618 |
3,502 |
$244K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
2,927 |
2,788 |
$240K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
3,900 |
3,831 |
$229K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
1,073 |
1,052 |
$169K |
| 74018 |
|
25,060 |
17,077 |
$167K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,673 |
1,621 |
$163K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
1,194 |
1,160 |
$162K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,932 |
1,823 |
$150K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,930 |
7,806 |
$145K |
| 99205 |
Prolong outpt/office vis |
870 |
831 |
$142K |
| 93320 |
|
5,576 |
5,187 |
$141K |
| 80053 |
Comprehensive metabolic panel |
24,525 |
20,206 |
$132K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,202 |
1,182 |
$124K |
| 77014 |
|
1,367 |
503 |
$116K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
653 |
264 |
$113K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,551 |
3,335 |
$108K |
| 71046 |
Radiologic examination, chest; 2 views |
11,243 |
11,013 |
$103K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,125 |
982 |
$102K |
| 99233 |
Prolong inpt eval add15 m |
1,475 |
604 |
$98K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,863 |
3,835 |
$93K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,376 |
18,326 |
$93K |
| 99462 |
|
2,195 |
1,866 |
$89K |
| 76801 |
|
2,065 |
2,001 |
$88K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
43 |
42 |
$86K |
| 80050 |
General health panel |
2,324 |
2,104 |
$85K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,293 |
1,111 |
$84K |
| 92015 |
Determination of refractive state |
5,106 |
4,927 |
$82K |
| 76770 |
|
2,111 |
2,066 |
$79K |
| 76830 |
Ultrasound, transvaginal |
2,752 |
2,630 |
$71K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,543 |
2,455 |
$71K |
| 59514 |
|
115 |
105 |
$70K |
| 93000 |
|
5,204 |
5,130 |
$69K |
| 92134 |
|
2,908 |
2,810 |
$63K |
| 93325 |
|
7,393 |
6,611 |
$61K |
| 0002A |
|
3,496 |
3,468 |
$57K |
| 01961 |
|
166 |
160 |
$55K |
| 72082 |
|
1,259 |
1,241 |
$49K |
| 95782 |
|
466 |
448 |
$49K |
| 0001A |
|
3,827 |
3,781 |
$47K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,149 |
1,116 |
$47K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
2,101 |
2,098 |
$46K |
| 71250 |
|
864 |
833 |
$46K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,459 |
1,299 |
$44K |
| 69210 |
|
1,719 |
1,652 |
$44K |
| 99222 |
Initial hospital care, per day, moderate complexity |
494 |
469 |
$44K |
| 73130 |
|
2,810 |
2,115 |
$42K |
| 64643 |
|
350 |
342 |
$40K |
| 99334 |
|
998 |
997 |
$40K |
| 73630 |
|
3,614 |
2,844 |
$40K |
| 76506 |
|
2,646 |
2,139 |
$40K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,868 |
1,749 |
$39K |
| 99381 |
|
424 |
414 |
$38K |
| 73562 |
|
2,044 |
1,528 |
$38K |
| 99349 |
|
438 |
431 |
$38K |
| 95812 |
|
203 |
201 |
$37K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,006 |
972 |
$35K |
| J9035 |
Injection, bevacizumab, 10 mg |
607 |
520 |
$34K |
| 99243 |
|
354 |
349 |
$34K |
| 76642 |
|
1,220 |
1,111 |
$30K |
| 80061 |
Lipid panel |
4,324 |
4,218 |
$30K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
963 |
956 |
$29K |
| 73610 |
|
2,035 |
1,760 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,011 |
2,573 |
$27K |
| 88141 |
|
1,409 |
1,385 |
$27K |
| 73110 |
|
1,305 |
1,120 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,202 |
4,917 |
$26K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
108 |
107 |
$26K |
| 85027 |
|
8,519 |
6,943 |
$25K |
| 90791 |
Psychiatric diagnostic evaluation |
215 |
210 |
$24K |
| 64642 |
|
254 |
247 |
$23K |
| 76010 |
|
3,092 |
1,505 |
$22K |
| 99348 |
|
423 |
417 |
$22K |
| 76825 |
|
198 |
174 |
$22K |
| 76820 |
|
997 |
645 |
$21K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,179 |
4,067 |
$20K |
| 54150 |
|
239 |
237 |
$20K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
536 |
511 |
$20K |
| 90834 |
Psychotherapy, 45 minutes with patient |
338 |
159 |
$20K |
| 90461 |
|
3,818 |
3,407 |
$20K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,278 |
1,269 |
$19K |
| 82728 |
|
2,149 |
2,078 |
$17K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
156 |
152 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,110 |
1,065 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,080 |
837 |
$16K |
| 51728 |
|
82 |
79 |
$16K |
| 86077 |
|
478 |
434 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
522 |
323 |
$16K |
| 82378 |
|
1,181 |
976 |
$16K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
104 |
84 |
$15K |
| 95720 |
|
102 |
51 |
$15K |
| 94375 |
|
993 |
968 |
$14K |
| 99242 |
|
191 |
188 |
$14K |
| 77066 |
Tomosynthesis, mammo |
382 |
376 |
$14K |
| 83735 |
|
4,956 |
3,007 |
$14K |
| 90832 |
Psychotherapy, 30 minutes with patient |
243 |
203 |
$13K |
| 73030 |
|
972 |
821 |
$13K |
| 94726 |
|
1,510 |
1,486 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,054 |
847 |
$13K |
| 76813 |
|
206 |
202 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
731 |
681 |
$12K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
731 |
681 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,122 |
996 |
$12K |
| 99223 |
Prolong inpt eval add15 m |
100 |
93 |
$11K |
| 94060 |
|
1,363 |
1,340 |
$11K |
| 83615 |
|
3,328 |
2,890 |
$11K |
| 31575 |
|
236 |
228 |
$11K |
| 99157 |
|
94 |
78 |
$11K |
| 99347 |
|
261 |
261 |
$11K |
| 11721 |
|
963 |
900 |
$10K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
279 |
164 |
$10K |
| 84439 |
|
1,883 |
1,720 |
$10K |
| 0071A |
|
261 |
260 |
$10K |
| 83550 |
|
1,873 |
1,818 |
$10K |
| 0072A |
|
252 |
252 |
$10K |
| 99245 |
|
53 |
49 |
$9K |
| 20610 |
|
267 |
228 |
$9K |
| 94729 |
|
1,388 |
1,363 |
$9K |
| 85610 |
|
4,046 |
3,785 |
$9K |
| 82607 |
|
1,258 |
1,227 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
194 |
192 |
$9K |
| 85730 |
|
2,350 |
2,230 |
$8K |
| 74183 |
|
66 |
63 |
$8K |
| 73502 |
|
345 |
339 |
$8K |
| 99255 |
|
43 |
40 |
$8K |
| 92083 |
|
314 |
282 |
$8K |
| 49083 |
|
112 |
69 |
$8K |
| 76942 |
|
417 |
394 |
$8K |
| 83540 |
|
2,031 |
1,969 |
$7K |
| 84100 |
|
3,725 |
2,363 |
$7K |
| 17110 |
|
81 |
79 |
$7K |
| 87340 |
|
1,130 |
1,084 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
314 |
262 |
$7K |
| 99152 |
|
1,041 |
969 |
$7K |
| 64644 |
|
99 |
93 |
$7K |
| 59025 |
Fetal non-stress test |
271 |
240 |
$7K |
| 81001 |
|
5,071 |
4,531 |
$7K |
| 73590 |
|
612 |
495 |
$7K |
| 76827 |
|
198 |
174 |
$7K |
| 82746 |
|
868 |
843 |
$6K |
| 51797 |
|
68 |
65 |
$6K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
60 |
53 |
$6K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
106 |
106 |
$6K |
| 90961 |
|
250 |
250 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,499 |
1,811 |
$6K |
| 93970 |
|
246 |
220 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
94 |
92 |
$6K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
679 |
627 |
$6K |
| 86803 |
|
601 |
575 |
$6K |
| 85007 |
|
2,438 |
2,066 |
$6K |
| 51798 |
|
1,010 |
978 |
$6K |
| 88342 |
|
203 |
198 |
$6K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
68 |
68 |
$6K |
| 73560 |
|
691 |
545 |
$5K |
| 73552 |
|
377 |
323 |
$5K |
| 73080 |
|
243 |
219 |
$5K |
| 77072 |
|
631 |
629 |
$5K |
| 54161 |
|
40 |
40 |
$5K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
229 |
224 |
$5K |
| 94618 |
|
306 |
300 |
$5K |
| 93304 |
|
95 |
80 |
$5K |
| 99253 |
|
52 |
51 |
$5K |
| 95816 |
|
120 |
117 |
$5K |
| 78306 |
|
27 |
27 |
$5K |
| 93922 |
|
404 |
384 |
$4K |
| 01968 |
|
25 |
25 |
$4K |
| 73090 |
|
343 |
286 |
$4K |
| 93227 |
|
311 |
302 |
$4K |
| 92133 |
|
139 |
136 |
$4K |
| 82105 |
|
553 |
519 |
$4K |
| 72100 |
|
411 |
405 |
$4K |
| 76536 |
|
156 |
151 |
$4K |
| 99254 |
|
28 |
28 |
$4K |
| 81003 |
|
4,310 |
3,442 |
$4K |
| 82248 |
|
1,538 |
1,196 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
225 |
182 |
$3K |
| 77065 |
Tomosynthesis, mammo |
116 |
110 |
$3K |
| 92504 |
|
619 |
544 |
$3K |
| 30802 |
|
44 |
38 |
$3K |
| 54160 |
|
27 |
27 |
$3K |
| 80074 |
|
87 |
83 |
$3K |
| 85390 |
|
602 |
500 |
$3K |
| 85652 |
|
1,994 |
1,960 |
$3K |
| 95811 |
|
26 |
26 |
$3K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
38 |
38 |
$3K |
| 84550 |
|
957 |
810 |
$3K |
| 20552 |
|
97 |
95 |
$3K |
| 87807 |
|
211 |
208 |
$3K |
| 80076 |
|
488 |
465 |
$3K |
| 73564 |
|
78 |
55 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
36 |
36 |
$2K |
| 83020 |
|
407 |
338 |
$2K |
| 95886 |
|
14 |
14 |
$2K |
| 93975 |
|
51 |
36 |
$2K |
| 95874 |
|
185 |
175 |
$2K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
221 |
90 |
$2K |
| 74178 |
|
12 |
12 |
$2K |
| 99335 |
|
34 |
33 |
$2K |
| 80503 |
|
132 |
122 |
$2K |
| 73521 |
|
130 |
128 |
$2K |
| 51784 |
|
87 |
82 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,192 |
1,032 |
$2K |
| 94010 |
|
271 |
250 |
$2K |
| 31622 |
|
29 |
25 |
$2K |
| 88112 |
|
98 |
84 |
$2K |
| 95813 |
|
25 |
25 |
$2K |
| 88341 |
|
15 |
15 |
$2K |
| 99384 |
|
13 |
13 |
$2K |
| 72157 |
|
12 |
12 |
$2K |
| 86850 |
|
927 |
811 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
21 |
13 |
$1K |
| 96367 |
|
54 |
51 |
$1K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
165 |
161 |
$1K |
| 88350 |
|
29 |
27 |
$1K |
| 82950 |
|
382 |
373 |
$1K |
| 0004A |
|
84 |
84 |
$1K |
| 88302 |
|
203 |
192 |
$1K |
| 77073 |
|
55 |
55 |
$1K |
| 30801 |
|
23 |
23 |
$1K |
| 70486 |
|
38 |
38 |
$1K |
| 84153 |
|
152 |
145 |
$1K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
25 |
25 |
$1K |
| 86704 |
|
133 |
128 |
$1K |
| 96160 |
|
422 |
419 |
$1K |
| 72170 |
|
61 |
57 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
70 |
68 |
$1K |
| 59430 |
|
12 |
12 |
$1K |
| 0124A |
|
44 |
44 |
$1K |
| 90836 |
|
17 |
12 |
$1K |
| 99155 |
|
14 |
12 |
$1K |
| 85576 |
|
262 |
146 |
$984.43 |
| 99382 |
|
12 |
12 |
$938.57 |
| 82550 |
|
256 |
230 |
$899.23 |
| 74455 |
|
13 |
13 |
$887.58 |
| 87428 |
|
25 |
19 |
$865.70 |
| 84703 |
|
1,094 |
1,015 |
$857.39 |
| 99156 |
|
13 |
13 |
$847.44 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
761 |
729 |
$832.79 |
| 93321 |
|
94 |
78 |
$820.42 |
| 99221 |
|
14 |
12 |
$815.99 |
| 0111A |
|
20 |
20 |
$800.00 |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
17 |
16 |
$796.67 |
| 72141 |
|
14 |
14 |
$769.10 |
| 95117 |
|
91 |
56 |
$742.99 |
| 83690 |
|
328 |
299 |
$741.47 |
| 96417 |
|
14 |
12 |
$695.39 |
| 82977 |
|
164 |
146 |
$692.70 |
| 88304 |
|
67 |
66 |
$680.48 |
| 88142 |
|
45 |
39 |
$664.53 |
| 72110 |
|
32 |
31 |
$662.61 |
| 87070 |
|
503 |
466 |
$662.49 |
| 74019 |
|
64 |
64 |
$640.90 |
| 86708 |
|
76 |
71 |
$605.80 |
| 0154A |
|
15 |
15 |
$560.00 |
| 0112A |
|
14 |
14 |
$560.00 |
| 76882 |
|
31 |
24 |
$553.47 |
| 90686 |
|
3,118 |
2,925 |
$539.40 |
| 88313 |
|
77 |
67 |
$517.49 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
13 |
12 |
$495.84 |
| 99383 |
|
16 |
16 |
$491.87 |
| 86780 |
|
466 |
440 |
$481.40 |
| 72050 |
|
12 |
12 |
$474.57 |
| 88348 |
|
27 |
26 |
$473.88 |
| 88312 |
|
12 |
12 |
$470.77 |
| 93880 |
|
12 |
12 |
$456.46 |
| 77080 |
|
39 |
39 |
$432.60 |
| 93971 |
|
43 |
39 |
$429.80 |
| 51741 |
|
80 |
75 |
$399.16 |
| 71271 |
|
12 |
12 |
$373.76 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
129 |
125 |
$369.13 |
| 86255 |
|
77 |
64 |
$321.58 |
| 0012A |
|
160 |
159 |
$316.97 |
| 83655 |
|
27 |
27 |
$304.20 |
| 92020 |
|
24 |
24 |
$301.32 |
| 73070 |
|
55 |
44 |
$294.69 |
| 84165 |
|
145 |
139 |
$279.76 |
| 95251 |
|
12 |
12 |
$272.61 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
215 |
178 |
$271.72 |
| 99417 |
Prolong home eval add 15m |
17 |
17 |
$265.94 |
| 88346 |
|
29 |
27 |
$258.35 |
| 99442 |
|
34 |
31 |
$251.81 |
| 93923 |
|
33 |
33 |
$243.34 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
233 |
200 |
$230.17 |
| 93926 |
|
13 |
12 |
$210.39 |
| 0011A |
|
145 |
143 |
$203.03 |
| 90670 |
|
2,055 |
1,997 |
$201.89 |
| 86706 |
|
30 |
27 |
$183.32 |
| 80069 |
|
96 |
69 |
$178.75 |
| 86317 |
|
12 |
12 |
$162.50 |
| 0003A |
|
31 |
31 |
$160.00 |
| 84702 |
|
26 |
26 |
$149.28 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
146 |
139 |
$139.06 |
| 86256 |
|
41 |
40 |
$123.23 |
| 99443 |
|
27 |
27 |
$118.89 |
| 95115 |
|
16 |
15 |
$118.31 |
| 72040 |
|
13 |
13 |
$117.55 |
| 90473 |
|
13 |
12 |
$105.44 |
| 95012 |
|
12 |
12 |
$100.08 |
| 98960 |
|
14 |
14 |
$95.08 |
| 96158 |
|
14 |
12 |
$93.23 |
| 82247 |
|
256 |
108 |
$84.89 |
| 95970 |
|
13 |
13 |
$83.83 |
| 73060 |
|
15 |
13 |
$83.26 |
| 93990 |
|
81 |
77 |
$76.07 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12 |
12 |
$75.00 |
| 0064A |
|
16 |
16 |
$40.00 |
| 86900 |
|
32 |
31 |
$32.03 |
| 86901 |
|
32 |
31 |
$32.03 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
91 |
83 |
$28.75 |
| 84484 |
|
12 |
12 |
$24.08 |
| 86140 |
|
18 |
17 |
$21.90 |
| 82962 |
|
741 |
347 |
$11.11 |
| 86762 |
|
13 |
13 |
$9.87 |
| 82570 |
|
33 |
28 |
$9.79 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
32 |
28 |
$2.56 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
25 |
24 |
$0.89 |
| 91300 |
|
6,271 |
5,625 |
$0.05 |
| 90677 |
|
270 |
260 |
$0.05 |
| 90715 |
|
72 |
69 |
$0.03 |
| 91301 |
|
159 |
156 |
$0.02 |
| 3078F |
|
13,741 |
13,427 |
$0.00 |
| 90710 |
|
358 |
353 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
258 |
243 |
$0.00 |
| 3077F |
|
233 |
229 |
$0.00 |
| 90672 |
|
182 |
178 |
$0.00 |
| 90648 |
|
1,171 |
1,140 |
$0.00 |
| 90633 |
|
975 |
961 |
$0.00 |
| 90707 |
|
243 |
236 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
17 |
16 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
37 |
37 |
$0.00 |
| 91312 |
|
43 |
43 |
$0.00 |
| 90734 |
|
124 |
121 |
$0.00 |
| 91311 |
|
62 |
60 |
$0.00 |
| 3046F |
|
27 |
25 |
$0.00 |
| 99173 |
|
14 |
14 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
29 |
28 |
$0.00 |
| 92552 |
|
14 |
14 |
$0.00 |
| 1036F |
|
17,656 |
17,136 |
$0.00 |
| 1000F |
|
19,068 |
18,522 |
$0.00 |
| 3008F |
|
22,190 |
21,566 |
$0.00 |
| 3351F |
|
547 |
533 |
$0.00 |
| 3074F |
|
10,638 |
10,407 |
$0.00 |
| 90680 |
|
1,061 |
1,047 |
$0.00 |
| 90698 |
|
637 |
635 |
$0.00 |
| 3044F |
|
8,229 |
8,004 |
$0.00 |
| 1034F |
|
785 |
749 |
$0.00 |
| 3079F |
|
628 |
619 |
$0.00 |
| 90696 |
|
266 |
263 |
$0.00 |
| 1220F |
|
152 |
150 |
$0.00 |
| 90723 |
|
1,083 |
1,056 |
$0.00 |
| 3075F |
|
965 |
941 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
41 |
40 |
$0.00 |
| 90651 |
|
388 |
376 |
$0.00 |
| 90716 |
|
216 |
210 |
$0.00 |
| 91307 |
|
684 |
643 |
$0.00 |
| 91315 |
|
15 |
15 |
$0.00 |
| 90619 |
|
80 |
79 |
$0.00 |
| 90688 |
|
56 |
54 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
14 |
14 |
$0.00 |
| 86880 |
|
27 |
27 |
$0.00 |